Extravasation After [177Lu]Lu-HA-DOTATATE Therapy

被引：1
|
作者：
de Vries-Huizing, Daphne M. V. [1 ]
Cheung, Zing J. [1 ]
Hendrikx, Jeroen J. M. A. [1 ,2 ]
Donswijk, Maarten L. [1 ]
Versleijen, Michelle W. J. [1 ]
机构：
[1] Netherlands Canc Inst, ENETS Ctr Excellence, Dept Nucl Med, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, ENETS Ctr Excellence, Dept Pharm & Pharmacol, Amsterdam, Netherlands
来源：
CLINICAL NUCLEAR MEDICINE | 2024年 / 49卷 / 05期
关键词：
extravasation; lutetium; neuroendocrine tumors; SPECT imaging; MANAGEMENT;
D O I：
10.1097/RLU.0000000000005137
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Extravasation of the radiopharmaceutical during peptide receptor radionuclide therapy infusion is an unwanted infrequently reported event. We present the case of a 74-year old woman with a neuroendocrine tumor who was referred for peptide receptor radionuclide therapy. During intravenous infusion of 7.4 GBq [Lu-177]Lu-HA-DOTATATE in the upper right arm, extravasation of the radiopharmaceutical occurred through a displaced intravenous catheter. Planar scintigraphy showed pooling of radioactivity in the right upper arm. After 24 hours, the swelling in the arm was decreased; however, erythema was increased. One week later, symptoms had disappeared, and the patient did not experience any complications during follow-up of 11 months.
引用
收藏
页码：454 / 456
页数：3
相关论文
共 50 条
  • [1] The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE
    Veerman, Chayenne H. A. M.
    Siebinga, Hinke
    de Vries-Huizing, Daphne M. V.
    Tesselaar, Margot E. T.
    Hendrikx, Jeroen J. M. A.
    Stokkel, Marcel P. M.
    Aalbersberg, Else A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) : 1434 - 1441
  • [2] The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE
    Chayenne H. A. M. Veerman
    Hinke Siebinga
    Daphne M. V. de Vries-Huizing
    Margot E. T. Tesselaar
    Jeroen J. M. A. Hendrikx
    Marcel P. M. Stokkel
    Else A. Aalbersberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1434 - 1441
  • [3] Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough
    Hinke Siebinga
    Chayenne H. A. M. Veerman
    Linda de Wit-van der Veen
    Marcel P. M. Stokkel
    Jeroen J. M. A. Hendrikx
    Else A. Aalbersberg
    EJNMMI Research, 12
  • [4] Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough
    Siebinga, Hinke
    Veerman, Chayenne H. A. M.
    de Wit-van der Veen, Linda
    Stokkel, Marcel P. M.
    Hendrikx, Jeroen J. M. A.
    Aalbersberg, Else A. A.
    EJNMMI RESEARCH, 2022, 12 (01)
  • [5] Letter to the editor regarding “The effect of long-acting somatostatin analogs on the uptake of [177Lu]Lu-HA-DOTATATE”
    Rang Wang
    Linlin Guo
    Guohua Shen
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 51 : 180 - 182
  • [6] Letter to the editor regarding "The effect of long-acting somatostatin analogs on the uptake of [177Lu]Lu-HA-DOTATATE"
    Wang, Rang
    Guo, Linlin
    Shen, Guohua
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 51 (01) : 180 - 182
  • [7] The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy
    Siebinga, H.
    Hendrikx, J. J. M. A.
    de Vries-Huizing, D. M. V.
    Huitema, A. D. R.
    de Wit-van der Veen, B. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 820 - 827
  • [8] The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy
    H. Siebinga
    J. J. M. A. Hendrikx
    D. M. V. de Vries-Huizing
    A. D. R. Huitema
    B. J. de Wit-van der Veen
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 820 - 827
  • [9] Occupational radiation exposure of nuclear medicine personnel during administration of [177Lu]Lu-HA-DOTATATE with two different administration devices
    Woudsma, S.
    Mylvaganan-Young, C.
    De Vries-Huizing, D. M. V.
    Sutherland-Van den Heuvel, I.
    Stokkel, M. P. M.
    Sonneborn-Bols, M.
    Aalbersberg, E. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S202 - S202
  • [10] Incorporation Of 177Lu During Care Of 177Lu-PSMA And 177Lu-DOTATATE Therapy Patients
    Happel, C.
    Kranert, W. T.
    Bockisch, B.
    Kratzel, U.
    Baumgarten, J.
    Ngoc, C. Nguyen
    Garayev, E.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S842 - S843
12345